Guidelines endorsed by EHA

Below, you’ll find a definitive list of guidelines produced by societies that we endorse.

Please note that EHA is not accepting endorsement requests until the end of 2025.

Hereditary hemorrhagic telangiectasia

• EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia 

Infections

• EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the ECMM in Cooperation with ISHAM and ASM 
• EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation with the International Society for Human and Animal Mycology and American Society for Microbiology 

Lymphomas

• EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas  
• EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma 
• EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma 
• Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines 

Myelodysplastic syndrome (MDS)

• EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT  

Waldenström’s macroglobulinemia

• EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia